当前景观和新兴的治疗目标在糖尿病病中
Shuai Hu1, Kyung Lee2, John Cijiang He2,3
1Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China.
糖尿病病 (DKD) 管理已经超越葡萄糖控制,发展为心血管--代谢方法. 新疗法针对炎症,纤维化和代谢功能障碍,以改善长期脏结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
背景情况:
- 糖尿病病 (DKD) 是全球末期病的主要原因.
- 目前的管理重点是心血管--代谢 (CKM) 综合征,利用RAASi,SGLT2i,GLP-1RAs和ns-MRAs.
- 尽管取得了进展,但显著的残留风险需要新的治疗策略.
研究的目的:
- 审查DKD目前的治疗环境.
- 探索 DKD 的新兴目标和研究疗法.
- 讨论DKD管理和个性化治疗的未来方向.
主要方法:
- 关于DKD病变发生的机制研究的审查.
- 对DKD目前和新兴治疗支柱的分析.
- 讨论临床翻译方面的挑战和机遇.
主要成果:
- 这四个基础支柱 (RAASi,SGLT2i,GLP-1RAs,ns-MRAs) 针对的是补充的途径,以减缓DKD的进展.
- 新兴疗法侧重于遗传/表观遗传因素,代谢障碍,炎症,纤维化和干细胞干预.
- 个性化治疗策略需要通过生物标志物引导的患者分层和组合疗法来解决残留风险.
结论:
- 未来的DKD管理包括将新疗法转化为临床实践.
- 克服临床试验设计和患者分层方面的挑战至关重要.
- 个性化,协同效应的组合疗法是提高长期脏结果的关键.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
相关概念视频
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Chronic Kidney Disease IV: Nursing Management
